ACT-28607-93194
5 vaccinations
6 coded responses
37 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 049 / ME
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Pfizer-BioNTech
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
-
2021-03-30
Survey response — day 14, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Soreness at injection site the day after checking in stopped.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal, Pyrexia — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Brain fog, feel feverish but am notMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-20
- 2021-04-29
-
2021-05-04
Survey response — day 28, dose 2MedDRA: Chest pain, Hospitalisation, Nausea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Chest pain and extreme nausea leading to ED admission last Tuesday night. Ruled out cardiac issues and pulmonary embolus. Workup for gallbladder issues or other diagnosis ongoing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-11
-
2021-05-18
Survey response — day 42, dose 2MedDRA: Discomfort, Eructation, Flatulence, Gallbladder disorder — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Experienced gallbladder attack week 3 post 2nd shot. Symptoms continue to ebb and flow. No abnormal labs, negative ultrasound. Monitoring under the care of my PC physician to see if this resolves. Still experiencing discomfort, burping, gas.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-06
- 2021-10-05
-
2021-11-17
Dose 3 — Moderna
- 2021-12-30
-
2022-03-26
Dose 4 — Moderna
- 2022-04-06
- 2022-04-25
- 2022-04-30
- 2022-05-07
-
2022-06-25
Survey response — 3 months, dose 4MedDRA: COVID-19, Cough, Fatigue, Headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID infection. Fatigue, cough, headache.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-24
-
2022-09-27
Dose 5 — ModernaCo-administered: Flu
-
2022-10-09
Health check-in — day 7, dose 5Feeling: Good · Site: Pain · Chills, Fatigue or tirednessAdult check-in
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-12-27
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-11-17 | Moderna | No |
| 4 | 2022-03-26 | Moderna | No |
| 5 | 2022-09-27 | Moderna | Flu |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — day 14, dose 1
Symptoms: Soreness at injection site the day after checking in stopped.
Release 7 — day 0, dose 2
Systemic reaction (other): None
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Brain fog, feel feverish but am not
Release 8 — day 28, dose 2
Symptoms: Chest pain and extreme nausea leading to ED admission last Tuesday night. Ruled out cardiac issues and pulmonary embolus. Workup for gallbladder issues or other diagnosis ongoing.
Release 8 — day 42, dose 2
Symptoms: Experienced gallbladder attack week 3 post 2nd shot. Symptoms continue to ebb and flow. No abnormal labs, negative ultrasound. Monitoring under the care of my PC physician to see if this resolves. Still experiencing discomfort, burping, gas.
Release 12 — 3 months, dose 4
Symptoms: COVID infection. Fatigue, cough, headache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Discomfort | ✓ | ✓ | ✓ |
| SD | Eructation | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Flatulence | ✓ | ✓ | ✓ |
| SD | Gallbladder disorder | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release